Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD
- Conditions
- Dry Age-related Macular DegenerationDetachment of the Posterior Hyaloid
- Interventions
- Device: ultrasoundDevice: OCT
- Registration Number
- NCT00926861
- Lead Sponsor
- The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
- Brief Summary
Choroidal neovascularisation in age related macular degeneration is one of the major causes of legal blindness in the western world existing in two major occurences, the dry and the wet form.The etiology of age related macular degeneration is yet unknown. Genetic factors, oxidative stress, Ischaemia, and aging of the retinal pigment epithelium are discussed as etiologic factors. The risk of rapid vision loss is much higher in wet AMD, a dry form may transform to a wet form. From a prior study the investigators know that the posterior hyaloid is significantly more frequent attached in wet AMD. This study is conducted to examine whether the attached posterior hyaloid is a risk factor to develop wet AMD in dry AMD cases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 320
- Dry MD
- Age over 50 years
- Macular pathologies other than age related macular degeneration (like diabetic maculopathy, macular pucker, macular hole)
- Prior vitrectomy or buckle surgery
- Uveitis posterior, multifocal chorioiditis
- Pathologic myopia
- Diabetic retinopathy
- Visualization of the macula not possible (dens cataract, vitreous haemorrhage)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Dry AMD ultrasound male or female persons aged over 50 years with dry age-related macular degeneration Dry AMD OCT male or female persons aged over 50 years with dry age-related macular degeneration
- Primary Outcome Measures
Name Time Method Number of eyes with non-exudative AMD with attached and detached posterior vitreous cortex developing exudative AMD 24 months
- Secondary Outcome Measures
Name Time Method Distance acuity 24 months Age 24 months Smoking 24 months Obesity 24 months Lesion classification (AREDS) 24 months
Trial Locations
- Locations (1)
Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery
🇦🇹Vienna, Austria